Literature DB >> 25195990

Quantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy.

Qianyi Xu1, George Hanna2, Jimm Grimm3, Gregory Kubicek2, Niraj Pahlajani4, Sucha Asbell2, Jiajin Fan5, Yan Chen2, Tamara LaCouture2.   

Abstract

PURPOSE: To quantify rigid and nonrigid motion of liver tumors using reconstructed 3-dimensional (3D) fiducials from stereo imaging during CyberKnife-based stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: Twenty-three liver patients treated with 3 fractions of SBRT were used in this study. After 2 orthogonal kilovoltage images were taken during treatment, the 3D locations of the fiducials were generated by the CyberKnife system and validated using geometric derivations. A total of 4824 pairs of kilovoltage images from start to end of treatment were analyzed. For rigid motion, the rotational angles and translational shifts were reported by aligning 3D fiducial groups from different image pairs, using least-squares fitting. For nonrigid motion, we quantified interfractional tumor volume variations by using the proportional volume derived from the fiducials, which correlates to the sum of interfiducial distances. The individual fiducial displacements were also reported (1) after rigid corrections and (2) without angle corrections.
RESULTS: The proportional volume derived by the fiducials demonstrated a volume-increasing trend in the second (101.9% ± 3.6%) and third (101.0 ± 5.9%) fractions among most patients, possibly due to radiation-induced edema. For all patients, the translational shifts in left-right, anteroposterior, and superoinferior directions were 2.1 ± 2.3 mm, 2.9 ± 2.8 mm, and 6.4 ± 5.5 mm, respectively. The greatest translational shifts occurred in the superoinferior direction, likely due to respiratory motion from the diaphragm. The rotational angles in roll, pitch, and yaw were 1.2° ± 1.8°, 1.8° ± 2.4°, and 1.7° ± 2.1°, respectively. The 3D individual fiducial displacements with rigid corrections were 0.2 ± 0.2 mm and increased to 0.5 ± 0.4 mm without rotational corrections.
CONCLUSIONS: Accurate 3D locations of internal fiducials can be reconstructed from stereo imaging during treatment. As an effective surrogate to tumor motion, fiducials provide a close estimation of both rigid and nonrigid motion of liver tumors. The reported displacements could be further utilized for tumor margin definition and motion management in conventional linear accelerator-based liver SBRT.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25195990     DOI: 10.1016/j.ijrobp.2014.05.007

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Retrospective assessment of a single fiducial marker tracking regimen with robotic stereotactic body radiation therapy for liver tumours.

Authors:  Masao Nakayama; Kazuyuki Uehara; Hideki Nishimura; Shuhei Tamura; Yoshiki Munetomo; Shinji Tsudou; Hiroshi Mayahara; Naritoshi Mukumoto; Moshi Geso; Ryohei Sasaki
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-21

2.  Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma.

Authors:  Anand Mahadevan; Nergiz Dagoglu; Joseph Mancias; Kristin Raven; Khalid Khwaja; Jennifer F Tseng; Kimmie Ng; Peter Enzinger; Rebecca Miksad; Andrea Bullock; Amy Evenson
Journal:  J Cancer       Date:  2015-08-01       Impact factor: 4.207

3.  Respiration-Induced Intraorgan Deformation of the Liver: Implications for Treatment Planning in Patients Treated With Fiducial Tracking.

Authors:  Anna K Paulsson; Sue S Yom; Mekhail Anwar; Dilini Pinnaduwage; Atchar Sudhyadhom; Alexander R Gottschalk; Albert J Chang; Martina Descovich
Journal:  Technol Cancer Res Treat       Date:  2017-01-10

4.  Dosimetric and clinical effects of interfraction and intrafraction correlation errors during marker-based real-time tumor tracking for liver SBRT.

Authors:  Keita Kurosu; Iori Sumida; Osamu Suzuki; Hiroya Shiomi; Seiichi Ota; Keisuke Otani; Keisuke Tamari; Yuji Seo; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

5.  Evaluation of the intra- and interfractional tumor motion and variability by fiducial-based real-time tracking in liver stereotactic body radiation therapy.

Authors:  Zhiwen Liang; Hongyuan Liu; Jun Xue; Bin Hu; Bin Zhu; Qin Li; Sheng Zhang; Gang Wu
Journal:  J Appl Clin Med Phys       Date:  2018-02-28       Impact factor: 2.102

6.  Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models.

Authors:  Anand Mahadevan; Bahman Emami; Jimm Grimm; Lawrence R Kleinberg; Kristin J Redmond; James S Welsh; Robert Rostock; Eric Kemmerer; Kenneth M Forster; Jason Stanford; Sunjay Shah; Sucha O Asbell; Tamara A LaCouture; Carla Scofield; Ian Butterwick; Jinyu Xue; Alexander Muacevic; John R Adler
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

7.  Impact on liver position under breath-hold by computed tomography contrast agents in stereotactic body radiotherapy of liver cancer.

Authors:  Hideharu Miura; Shuichi Ozawa; Minoru Nakao; Yoshiko Doi; Katsumaro Kubo; Masahiro Kenjo; Yasushi Nagata
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

8.  Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy.

Authors:  Sharmi Biswas; Irina Kapitanova; Sabrina Divekar; Jimm Grimm; Ian J Butterwick; Daniel Garren; Lawrence R Kleinberg; Kristin J Redmond; Michel Lacroix; Anand Mahadevan; Kenneth M Forster
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

9.  Real-Time Wireless Tumor Tracking in Navigated Liver Resections: An Ex Vivo Feasibility Study.

Authors:  Roeland Eppenga; Wout Heerink; Jasper Smit; Koert Kuhlmann; Theo Ruers; Jasper Nijkamp
Journal:  Ann Surg Oncol       Date:  2022-02-23       Impact factor: 4.339

10.  Estimating intrafraction tumor motion during fiducial-based liver stereotactic radiotherapy via an iterative closest point (ICP) algorithm.

Authors:  Wu-Zhou Li; Zhi-Wen Liang; Yi Cao; Ting-Ting Cao; Hong Quan; Zhi-Yong Yang; Qin Li; Zhi-Tao Dai
Journal:  Radiat Oncol       Date:  2019-10-29       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.